Entrada Therapeutics Inc Financial Flexibility Index
Entrada Therapeutics Inc financial flexibility index. Entrada Therapeutics Inc (TRDA) has a Financial Flexibility Index of -0.50x as of June 2026. Free cash flow of $-32.45 Million (operating CF $-32.46 Million minus capex $11.00K) represents 0% of total liabilities ($65.47 Million). See Entrada Therapeutics Inc free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Entrada Therapeutics Inc (2019–2025)
Financial flexibility index of Entrada Therapeutics Inc from 2019 to 2025. Historical Financial Flexibility Index trend for Entrada Therapeutics Inc across 7 annual periods. Check earnings quality score of Entrada Therapeutics Inc to evaluate the quality of earnings relative to operating cash generation.
Entrada Therapeutics Inc Financial Flexibility Index by Year (2019–2025)
Entrada Therapeutics Inc financial flexibility index by year from 2019 to 2025. Year-by-year free cash flow to debt coverage for Entrada Therapeutics Inc. For the full cash flow conversion analysis, see cash flow conversion of Entrada Therapeutics Inc.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.79x | $-127.47 Million | $-128.51 Million | $71.25 Million | ▼ -355.0% |
| 2024 | -0.39x | $-38.40 Million | $-41.56 Million | $97.64 Million | ▼ -161.3% |
| 2023 | 0.64x | $145.42 Million | $139.80 Million | $226.83 Million | ▲ +127.9% |
| 2022 | -2.30x | $-90.90 Million | $-93.79 Million | $39.50 Million | ▲ +64.6% |
| 2021 | -6.50x | $-46.28 Million | $-50.86 Million | $7.12 Million | ▼ -2278.4% |
| 2020 | -0.27x | $-23.25 Million | $-25.57 Million | $85.02 Million | ▲ +9.2% |
| 2019 | -0.30x | $-10.17 Million | $-10.80 Million | $33.76 Million | — |